Barbara Wells
Annapolis, MDNPI 1376520965
Payments from drug & device makers
$1,309in general payments, 2019–2025
Across 63 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$200
- Hologic Sales And Service, LLC$143
- Astellas Pharma US Inc$140
- Johnson & Johnson$114
- Bayer$109
- Sage Therapeutics, LLC$77
- plus $526 from 15 others
What the payments were for
- Food & beverage$1,24595%
- Education$645%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $200 |
| Hologic Sales And Service, LLC | 6 | $143 |
| Astellas Pharma US Inc | 6 | $140 |
| Johnson & Johnson | 3 | $114 |
| Bayer | 7 | $109 |
| Sage Therapeutics, LLC | 4 | $77 |
| Therapeuticsmd, Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $67 |
| Dysis Medical, Inc. | 1 | $58 |
| Merck | 4 | $56 |
| Mayne Pharma Commercial LLC | 3 | $40 |
| AMAG Pharmaceuticals, Inc. | 2 | $37 |
| Pfizer | 2 | $37 |
| Mylan Pharmaceuticals Inc. | 2 | $32 |
| Millicent US Inc | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Medicem Inc. | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Organon | 1 | $18 |
| Coopersurgical, Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.